Clinical trials
Wounds and Injuries trials in Brazil
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 4 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 21 |
| Unknown status | 8 |
| Recruiting | 3 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of Sao Paulo | 6 |
| Federal University of Rio Grande do Sul | 3 |
| Universidade Estadual Paulista Júlio de Mesquita Filho | 3 |
| Sangart | 2 |
| University of Sao Paulo General Hospital | 2 |
| AO Innovation Translation Center | 1 |
| CHU de Quebec-Universite Laval | 1 |
| Daiichi Sankyo Brasil Farmacêutica LTDA | 1 |
| Federal University of Piaui | 1 |
| Hospital Israelita Albert Einstein | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wounds and Injuries | 36 |
| Hemorrhage | 5 |
| Gingival Recession | 3 |
| Acidosis, Lactic | 2 |
| Burns | 2 |
| Diabetes Mellitus | 2 |
| Emergencies | 2 |
| Neoplasms | 2 |
| Pain | 2 |
| Sepsis | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.